Roche hemophilia drug wins FDA nod, with a warning

Published: 16/11/2017
Roche hemophilia drug wins FDA nod, with a warning
Source: FEEDS.REUTERS.COM

ZURICH (Reuters) - The U.S. Food and Drug Administration on Thursday approved Roche's Hemlibra, a new medicine for hemophilia A that the Swiss drugmaker is counting on to help to offset eroding sales of older medicines going off patent.

Read more
Related news
Comment